STAT+: Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics
Good morning. This is Jonathan with you once more. We’re now close enough to the weekend that it’s time to start making plans (or looking forward to the ones you’ve made), but far enough that there’s still plenty of work to do. Oh, the agony. Hope these engaging news items help ease the pain.
The Food and Drug Administration authorized new Covid booster shots that more closely match the strains of the coronavirus currently circulating in the U.S., STAT tells us. The FDA decision, which came yesterday, still requires the signoff of the Centers for Disease Control and Prevention. The agency’s vaccine advisory panel is scheduled to meet today and tomorrow, and could vote to recommend them as early as today.
Continue to STAT+ to read the full story…
